Exchange Announcement • 17 Nov 2022 21:00
Q3 2022
Exchange Announcement • 04 Aug 2022 16:49
Q2 2022
Exchange Announcement • 05 May 2022 16:49
Q1 2022
Exchange Announcement • 16 Mar 2022 08:00
Q4 2021
Exchange Announcement • 11 Nov 2021 08:00
𝛼SK or SearchENTITY
MorphoSys AG (MOR GR)
MorphoSys AG (MOR GR)
16
Analysis
Health Care • Germany
MorphoSys AG operates as a biopharmaceutical company. The Company discovers and develops differentiated therapies and medicines for the patients suffering from cancer, inflammations, and autoimmune diseases. MorphoSys serves customers in Germany.
morex